Approved indications: Oral nifedipine is approved to treat high blood pressure and to prevent or reduce episodes of chronic stable and vasospastic (Prinzmetal) angina.

Off‑label uses and evidence: Clinicians may use nifedipine off‑label for conditions such as Raynaud phenomenon or certain pregnancy‑related hypertensive disorders, generally supported by moderate clinical evidence, and sometimes for preterm labor or esophageal spasm where evidence and practice are more variable.

Efficacy expectations: Blood pressure often begins to improve within hours to days of starting therapy, with full effect over about 1–2 weeks, and many patients achieve meaningful blood‑pressure reductions and fewer angina attacks when dosed and titrated appropriately.

Comparison to similar drugs: Its blood‑pressure‑lowering and angina benefits are broadly comparable to other dihydropyridine calcium channel blockers (like amlodipine), though some alternatives offer longer half‑lives or smoother 24‑hour control.

Typical dosing: For adults with hypertension or angina, extended‑release nifedipine is commonly started around 30–60 mg once daily and adjusted gradually, with maximum doses often around 90–120 mg per day, depending on the specific product and patient response.

How to take: Swallow extended‑release tablets whole (do not crush, break, or chew), take consistently at the same time each day, and follow label directions about taking with or without food; some formulations should be taken on an empty stomach.

Special instructions: Do not stop nifedipine suddenly without medical guidance, as this may worsen chest pain or blood pressure control, and follow your prescriber’s instructions about checking blood pressure at home.

Missed dose: If you miss a dose, take it as soon as you remember unless it is almost time for the next dose; if it is close to the next dose, skip the missed dose and resume your regular schedule without doubling doses.

Overdose: In case of overdose or collapse, call emergency services or poison control right away, as overdose can cause dangerously low blood pressure, rapid heartbeat, or shock.

Common side effects: Common effects include headache, flushing, dizziness, palpitations, swelling of the ankles or feet, and fatigue, which often appear soon after starting or increasing the dose and are usually mild to moderate.

Serious or rare adverse effects: Seek urgent medical attention for severe dizziness or fainting, chest pain that worsens, shortness of breath, very fast heartbeat, signs of a heart attack or stroke, or signs of an allergic reaction such as rash, swelling of the face or tongue, or trouble breathing.

Warnings and precautions: Use with caution in people with very low blood pressure, heart failure, significant aortic stenosis, or recent heart attack, and in those with liver impairment who may need dose adjustments.

Pregnancy and breastfeeding: Nifedipine is sometimes used in pregnancy under specialist supervision when benefits outweigh risks, and small amounts pass into breast milk, so risks and benefits for breastfeeding should be discussed with a healthcare provider.

Relative safety: Overall, extended‑release nifedipine has a well‑established safety profile when used as directed, but can cause problematic drops in blood pressure or edema in some patients, and requires individualized selection compared with other blood‑pressure drugs.

Side‑effect reporting and safety updates: Side effects can be reported to the FDA MedWatch program, and updated safety information can be found on the FDA and manufacturer websites or through a pharmacist or prescriber.

Drug and supplement interactions: Nifedipine is metabolized by CYP3A4, so strong inhibitors (such as certain azole antifungals, macrolide antibiotics, HIV medications) can raise its levels, while strong inducers (such as rifampin, some seizure medicines, or St. John’s wort) can reduce its effect; it can also interact with other blood‑pressure or heart medicines, increasing the risk of low blood pressure or heart effects.

Food, alcohol, and other interactions: Grapefruit or grapefruit juice can significantly increase nifedipine levels and should generally be avoided, and alcohol may enhance blood‑pressure‑lowering and dizziness.

Precautions and conditions: Use cautiously or avoid in people with very low baseline blood pressure, unstable angina, severe aortic stenosis, decompensated heart failure, or significant liver disease, and let your clinician know about any other prescription drugs, over‑the‑counter medicines, or herbal supplements you take.

Monitoring needs: Regular monitoring of blood pressure and heart rate is recommended, and some patients may need periodic lab tests or additional heart evaluation based on their overall health and other medications.

Q: How long does it take for nifedipine to start lowering my blood pressure?
A: Blood pressure may begin to improve within hours to days of starting a dose, but it can take about 1–2 weeks to see the full effect, so keep taking it as prescribed unless your provider tells you otherwise.

Q: Can I stop taking nifedipine once my blood pressure is normal?
A: Do not stop nifedipine on your own; blood pressure usually rises again if it is stopped, so any change should be made gradually and only under your prescriber’s guidance.

Q: Is it safe to drink grapefruit juice with nifedipine?
A: Grapefruit and grapefruit juice can increase nifedipine levels and the risk of side effects, so they are usually avoided while taking this medicine.

Q: What should I do if I feel dizzy after taking nifedipine?
A: Sit or lie down until the dizziness passes, avoid driving or standing up quickly, and contact your healthcare provider if it is severe, persistent, or associated with chest pain, shortness of breath, or fainting.

Q: Can nifedipine be taken with other blood‑pressure medications?
A: Nifedipine is often combined with other blood‑pressure drugs, but this should be done only under medical supervision to choose compatible medicines and adjust doses to avoid overly low blood pressure.

Storage: Keep nifedipine tablets or capsules at room temperature away from moisture, heat, and direct light, in a tightly closed container, and out of reach of children and pets.

Disposal: Do not flush unless labeling specifically says to; use a take‑back program if available or follow local guidance for mixing unused tablets with unappealing trash in a sealed bag before discarding.